Retromer Therapeutics
PrivateCompany Overview
Retromer Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. It was founded in 2020.
Retromer Therapeutics is a biotechnology company that develops disease-modifying therapeutics for neurodegenerative diseases by enhancing endolysosomal transport and stabilizing the retromer pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Retromer Therapeutics Comparables
Compare Retromer Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arkuda Therapeutics | 83% | |
| Cantabio Pharmaceuticals | 82% | |
| Endlyz Therapeutics | 81% |
For institutional investors. Book with your work email.
Retromer Therapeutics Funding Rounds
Historical fundraising activity
Retromer Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Retromer Therapeutics's valuation, stock price, and market status.
Is Retromer Therapeutics a public or private company?
Retromer Therapeutics is a private company.
What is the current stock price of Retromer Therapeutics?
Retromer Therapeutics is a private company, so its shares have no public market price. Caplight tracks Retromer Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Retromer Therapeutics worth (valuation)?
Valuation information for Retromer Therapeutics is not publicly available.
Can I buy Retromer Therapeutics stock?
Retromer Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Retromer Therapeutics's last funding round?
Funding round information for Retromer Therapeutics is not publicly available.
Who are the main investors in Retromer Therapeutics?
Investor information for Retromer Therapeutics is not publicly disclosed.
Will Retromer Therapeutics IPO soon?
No public IPO plans have been announced for Retromer Therapeutics.
How can I track Retromer Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Retromer Therapeutics's shares on secondary markets.